Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.
作者信息
Vanlandschoot Peter, Van Houtte Freya, Serruys Benedikte, Leroux-Roels Geert
出版信息
J Virol. 2007 Mar;81(5):2535-6. doi: 10.1128/JVI.02507-06. Epub 2006 Dec 6.
Abstract
摘要
相似文献
1
Contamination of a recombinant hepatitis B virus nucleocapsid preparation with a human B-cell activator.
J Virol. 2007 Mar;81(5):2535-6. doi: 10.1128/JVI.02507-06. Epub 2006 Dec 6.
2
Display of the antigenic region of Nipah virus nucleocapsid protein on hepatitis B virus capsid.
J Biosci Bioeng. 2012 Jan;113(1):26-9. doi: 10.1016/j.jbiosc.2011.09.007. Epub 2011 Oct 24.
3
Sustained and focused hepatitis B virus nucleocapsid-specific T-cell immunity in liver transplant recipients compared to individuals with chronic and self-limited hepatitis B virus infection.
Liver Transpl. 2008 Apr;14(4):478-85. doi: 10.1002/lt.21384.
4
Purification of the recombinant hepatitis B virus core antigen (rHBcAg) produced in the yeast Saccharomyces cerevisiae and comparative observation of its particles by transmission electron microscopy (TEM) and atomic force microscopy (AFM).
Micron. 2004;35(5):311-8. doi: 10.1016/j.micron.2003.12.003.
5
In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
J Med Virol. 2009 Feb;81(2):332-9. doi: 10.1002/jmv.21333.
6
Characterization of sequence variations in immunodominant regions of the HBV-nucleocapsid protein as a prerequisite for the development of an epitope-based vaccine.
Vaccine. 2007 Jun 21;25(26):4960-6. doi: 10.1016/j.vaccine.2006.12.009. Epub 2006 Dec 22.
7
Expression and purification of the recombinant HBcAg core particles derived from methyltrophic Pichia pastoris, and TEM and AFM of the core particles and their natural aggregates.
J Electron Microsc (Tokyo). 2007 Dec;56(6):235-42. doi: 10.1093/jmicro/dfm028. Epub 2007 Oct 31.
8
Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
J Immunol. 2009 Jul 1;183(1):370-80. doi: 10.4049/jimmunol.0900505.
9
Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked.
J Gen Virol. 2005 Feb;86(Pt 2):323-331. doi: 10.1099/vir.0.80605-0.
10
Suitability of yeast- and Escherichia coli-expressed hepatitis B virus core antigen derivatives for detection of anti-HBc antibodies in human sera.
Protein Expr Purif. 2007 Dec;56(2):293-300. doi: 10.1016/j.pep.2007.08.004. Epub 2007 Aug 24.
引用本文的文献
1
Hepatitis B virus particles activate B cells through the TLR2-MyD88-mTOR axis.
Cell Death Dis. 2021 Jan 4;12(1):34. doi: 10.1038/s41419-020-03284-1.
2
Acute-on-Chronic Liver Failure From Chronic-Hepatitis-B, Who Is the Behind Scenes.
Front Microbiol. 2020 Dec 7;11:583423. doi: 10.3389/fmicb.2020.583423. eCollection 2020.
3
Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
Vaccines (Basel). 2018 Jan 16;6(1):6. doi: 10.3390/vaccines6010006.
4
Interplay between the Hepatitis B Virus and Innate Immunity: From an Understanding to the Development of Therapeutic Concepts.
Viruses. 2017 Apr 28;9(5):95. doi: 10.3390/v9050095.
5
Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
Cell Mol Immunol. 2015 May;12(3):273-82. doi: 10.1038/cmi.2014.112. Epub 2014 Nov 24.
6
Use of hepadnavirus core proteins as vaccine platforms.
Expert Rev Vaccines. 2009 Nov;8(11):1565-73. doi: 10.1586/erv.09.121.
7
Interaction of the hepatitis B core antigen and the innate immune system.
J Immunol. 2009 Jun 1;182(11):6670-81. doi: 10.4049/jimmunol.0803683.
8
Comparison of serum humoral responses induced by oral immunization with the hepatitis B virus core antigen and the cholera toxin B subunit.
Clin Vaccine Immunol. 2008 May;15(5):852-8. doi: 10.1128/CVI.00382-07. Epub 2008 Mar 26.
本文引用的文献
1
"Dirty little secrets"--endotoxin contamination of recombinant proteins.
Immunol Lett. 2006 Jul 15;106(1):1-7. doi: 10.1016/j.imlet.2006.04.007. Epub 2006 May 11.
2
The role of heparan sulfate and TLR2 in cytokine induction by hepatitis B virus capsids.
J Immunol. 2005 Nov 15;175(10):6253; author reply 6253-5. doi: 10.4049/jimmunol.175.10.6253.
3
Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN.
J Immunol. 2005 Apr 1;174(7):4043-50. doi: 10.4049/jimmunol.174.7.4043.
4
Immunostimulatory potential of hepatitis B nucleocapsid preparations: lipopolysaccharide contamination should not be overlooked.
J Gen Virol. 2005 Feb;86(Pt 2):323-331. doi: 10.1099/vir.0.80605-0.
5
The nucleocapsid of the hepatitis B virus: a remarkable immunogenic structure.
Antiviral Res. 2003 Oct;60(2):67-74. doi: 10.1016/j.antiviral.2003.08.011.
6
Hepatitis B virus core antigen binds and activates naive human B cells in vivo: studies with a human PBL-NOD/SCID mouse model.
J Virol. 2001 Jul;75(14):6359-66. doi: 10.1128/JVI.75.14.6359-6366.2001.
7
Role of B cells in antigen presentation of the hepatitis B core.
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14648-53. doi: 10.1073/pnas.94.26.14648.
8
Hepatitis B virus core antigen: synthesis in Escherichia coli and application in diagnosis.
Proc Natl Acad Sci U S A. 1982 Mar;79(5):1606-10. doi: 10.1073/pnas.79.5.1606.
Zotero 插件